SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Beryl Drugs inks pact with MPPHSCL for supply of the medicines

23 Jan 2015 Evaluate

Beryl Drugs has entered into an agreement with the Madhya Pradesh Public Health Services Procurement Corporation (MPPHSCL), Bhopal (M.P.) for supply of the medicines manufactured by the company to the tune of Rs 11.80 crore, which will boost up the company’s turnover by 60% to 65%.

Further, the company has expanded its production capacity from 1.20 crores bottles per year to 2.00 crore bottles per year to fulfill the present and the future requirements of the company.

The company is into manufacturing and marketing of branded, generic pharmaceutical formulations. The company is one of leading manufacturer of I.V.fluids and small volume injectables.

Beryl Drugs Share Price

20.59 0.59 (2.95%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×